Medical Facilities Corporation
TSX:DR.TOMedical - Care Facilities
+$0.18 today
- Market cap
- $282.59M
- Beta
- 0.34
- P/E (TTM)
- 8.7
- EPS (TTM)
- $1.47
- Dividend yield
- 2.00%
Volume 0.04M
Average 0.02M
DR.TO Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Medical Facilities CorporationTSX: DR.TO
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock falls 7.7% from a year ago
Common stock stood at $251.86M at the end of Q1 FY2026, down 7.7% from a year earlier and down 0.6% from the prior quarter. Over 3 fiscal years it compounded at -10.5% a year.
Context
- Common stock amounted to 90.6% of total assets at the end of Q1 FY2026, down 2.3 pp from a year earlier.
- Common stock increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps falling in the next quarterly balance sheet after a -7.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 253.47M USD
- Year-over-year change
- -20.0%
- 4-year CAGR
- -10.6%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 253.47M | -20.0% |
| FY2024 | 2024-12-31 | 316.93M | -9.0% |
| FY2023 | 2023-12-31 | 348.1M | -1.5% |
| FY2022 | 2022-12-31 | 353.24M | -10.8% |
| FY2021 | 2021-12-31 | 396.04M | — |
Common Stock vs competitors
How DR.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -7.7% is the lowest of 8, against a peer median of +5.0%.
- Common stock amounts to 90.6% of total assets for DR.TO, versus a peer median of 187.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$9.23B CAD | +5.0% | +5.2% | 825.4% | |
| Mar 2026 | CA$924.19M CAD | +0.8% | — | 177.3% | |
| Mar 2026 | CA$551.8M CAD | +1.6% | +7.3% | 197.3% | |
| Mar 2026 | CA$332.96M CAD | +0.1% | +3.5% | 133.8% | |
PRN.TOProfound Medical Corp. | Mar 2026 | $324.39M USD | +15.2% | +15.9% | 441.3% |
| Mar 2026 | $255.68M USD | +118.8% | +28.3% | 175.8% | |
| Mar 2026 | $251.86M USD | -7.7% | -10.5% | 90.6% | |
| Mar 2026 | $190.74M USD | +30.7% | +10.0% | 266.3% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding DR.TO) | — | +5.0% | +8.6% | 187.3% | |
Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 61.04M | 34.93M | 24.11M | 108.5M | 43.37M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 67.45M | 64.63M | 69.64M | 51.03M | 35.26M |
| Inventory | 10.65M | 9.23M | 9.01M | 5.81M | 5.82M |
| Other Current Assets | 0 | 587K | 733K | (5.48M) | 37.88M |
| Total Current Assets | 148.89M | 119.33M | 102.76M | 165.34M | 122.33M |
| Property, Plant & Equipment (Net) | 132.75M | 124.72M | 120.18M | 83M | 69.93M |
| Goodwill | 135.98M | 120.62M | 120.62M | 90.6M | 75.71M |
| Intangible Assets | 14.45M | 13.1M | 11.25M | 7.23M | 3.99M |
| Long-term Investments | 1.12M | 258.44M | 0 | 0 | 0 |
| Tax Assets | 386K | 20K | 70K | 129K | 171.69K |
| Other Non-current Assets | 13.38M | 0 | 0 | 0 | 0 |
| Total Non-current Assets | 298.07M | 258.46M | 252.13M | 180.96M | 149.8M |
| Total Assets | 446.97M | 377.79M | 354.89M | 346.29M | 272.14M |
| Account Payables | 23.94M | 26.4M | 23.15M | 16.94M | 15.34M |
| Short-term Debt | 5.3M | 9.73M | 14.35M | 10.39M | 3.35M |
| Tax Payables | 0 | 0 | 10K | 13.77M | 0 |
| Deferred Revenue | 15.84M | 12.34M | 0 | 0 | 0 |
| Other Current Liabilities | 17.8M | 18.29M | 15.61M | 16.69M | 27.09M |
| Total Current Liabilities | 88M | 86.82M | 82.96M | 88.95M | 68.47M |
| Long-term Debt | 74.28M | 75.86M | 54.75M | 23.83M | 26.9M |
| Deferred Tax Liabilities | 14.12M | 15.88M | 20.23M | 15.95M | 14.27M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 45.58M | 37.35M | 60.32M | 39.3M | 39.47M |
| Total Non-current Liabilities | 185.82M | 176.28M | 153.62M | 109.89M | 103.29M |
| Total Liabilities | 273.82M | 263.1M | 236.58M | 198.84M | 171.76M |
| Common Stock | 396.04M | 353.24M | 348.1M | 316.93M | 253.47M |
| Retained Earnings | (263.82M) | (275.3M) | (262.83M) | (195.38M) | (178.62M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | (0) | (1) | 0 | 0 | 0 |
| Minority Interest | 45.6M | 35.56M | 32.32M | 25.43M | 25.06M |
| Total Equity | 173.15M | 114.69M | 118.3M | 147.45M | 100.37M |
| Total Debt | 140.9M | 142.95M | 116.81M | 73.94M | 58.74M |
| Net Debt | 79.86M | 108.03M | 92.7M | (34.56M) | 15.37M |
Medical Facilities Corporation
TSX:DR.TO
Intrinsic Alpha fair value
Locked
Current Price
$17.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.